Cortical Dysplasia in Rats Provokes Neurovascular Alterations, GLUT1 Dysfunction, and Metabolic Disturbances That Are Sustained Post-Seizure Induction
Authors:
- 27 January 2022
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 59 (4) , 2389-2406
Abstract
Focal cortical dysplasia (FCD) is associated with blood-brain barrier (BBB) dysfunction in patients with difficult-to-treat epilepsy. However, the underlying cellular and molecular factors in cortical dysplasia (CD) associated with progressive neurovascular challenges during the pro-epileptic phase, post-seizure, and during epileptogenesis remain unclear. We studied the BBB function in a rat model of congenital (in utero radiation-induced, first hit) CD and longitudinally examined the cortical brain tissues at baseline and the progressive neurovascular alterations, glucose transporter-1 (GLUT1) expression, and glucose metabolic activity at 2, 15, and 30 days following a second hit using pentylenetetrazole-induced seizure. Our study revealed through immunoblotting, immunohistochemistry, and biochemical analysis that (1) altered vascular density and prolongation of BBB albumin leakages in CD rats continued through 30 days post-seizure; (2) CD brain tissues showed elevated matrix metalloproteinase-9 levels at 2 days post-seizure and microglial overactivation through 30 days post-seizure; (3) BBB tight junction protein and GLUT1 levels were decreased and neuronal monocarboxylate transporter-2 (MCT2) and mammalian target of rapamycin (mTOR) levels were increased in the CD rat brain: (4) ATPase activity is elevated and a low glucose/high lactate imbalance exists in CD rats; and (5) the mTOR pathway is activated and MCT2 levels are elevated in the presence of high lactate during glucose starvation in vitro. Together, this study suggests that BBB dysfunction, including decreased GLUT1 expression and metabolic disturbance, may contribute to epileptogenesis in this CD rat model through multiple mechanisms that could be translated to FCD therapy in medically refractory epilepsy.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS095825)
This publication has 53 references indexed in Scilit:
- Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesionsEpilepsia, 2012
- Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsyNeurobiology of Disease, 2012
- Blood–brain barrier dysfunction, status epilepticus, seizures, and epilepsy: A puzzle of a chicken and egg?Epilepsia, 2011
- Blood-Brain Barrier Dysfunction in Epileptogenesis of the Temporal LobeEpilepsy Research and Treatment, 2011
- Molecular cascades that mediate the influence of inflammation on epilepsyEpilepsia, 2011
- Engaging neuroscience to advance translational research in brain barrier biologyNature Reviews Neuroscience, 2011
- Blood–brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndromeJournal of Neurology, 2009
- The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe EpilepsyThe Journal of Neuroscience, 2009
- Blood–brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edemaEpilepsia, 2009
- The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose UptakeThe American Journal of Pathology, 2008